Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Capparelli

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Journal of Cellular Biochemistry|January 4, 1998
Apoptosis during bone-like tissue development in vitroM P Lynch, C Capparelli, J L Stein, et al.
Cancer Research|June 5, 2001
Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasisS Morony, C Capparelli, I Sarosi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1999
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3S Morony, C Capparelli, R Lee, et al.
Endocrinology|September 21, 2001
OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized ratsP J Kostenuik, C Capparelli, S Morony, et al.
Endocrinology|May 1, 1997
Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sexB Frenkel, C Capparelli, M Van Auken, et al.
Cancer Research|March 8, 2000
Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancyC Capparelli, P J Kostenuik, S Morony, et al.
Journal of Cellular Biochemistry|April 1, 1996
Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genesK T Tang, C Capparelli, J L Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosisB Bolon, C Carter, M Daris, et al.
The Journal of Experimental Medicine|August 22, 2000
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesisH Min, S Morony, I Sarosi, et al.
Genes & Development|June 6, 1998
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationN Bucay, I Sarosi, C R Dunstan, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Journal of Cellular Biochemistry|January 4, 1998
Apoptosis during bone-like tissue development in vitroM P Lynch, C Capparelli, J L Stein, et al.
Cancer Research|June 5, 2001
Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasisS Morony, C Capparelli, I Sarosi, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1999
A chimeric form of osteoprotegerin inhibits hypercalcemia and bone resorption induced by IL-1beta, TNF-alpha, PTH, PTHrP, and 1, 25(OH)2D3S Morony, C Capparelli, R Lee, et al.
Endocrinology|September 21, 2001
OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized ratsP J Kostenuik, C Capparelli, S Morony, et al.
Endocrinology|May 1, 1997
Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sexB Frenkel, C Capparelli, M Van Auken, et al.
Cancer Research|March 8, 2000
Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancyC Capparelli, P J Kostenuik, S Morony, et al.
Journal of Cellular Biochemistry|April 1, 1996
Acidic fibroblast growth factor inhibits osteoblast differentiation in vitro: altered expression of collagenase, cell growth-related, and mineralization-associated genesK T Tang, C Capparelli, J L Stein, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2001
Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosisB Bolon, C Carter, M Daris, et al.
The Journal of Experimental Medicine|August 22, 2000
Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesisH Min, S Morony, I Sarosi, et al.
Genes & Development|June 6, 1998
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcificationN Bucay, I Sarosi, C R Dunstan, et al.
Pageof 2